|
000
| 03133cam 2200445zi 4500 |
|---|
| 001 | 9.935235 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240620110958 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 240311t20242024onc ob f000 0 eng d |
|---|
| 020 | |a9780660707341 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-443/2024E-PDF |
|---|
| 245 | 00|aMpox immunization coverage survey among 2SLGBTQI+ and men who have sex with men, 2024 : |bmethodological report / |cprepared for the Public Health Agency of Canada. |
|---|
| 264 | 1|aOttawa, Ontario : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (33 pages) + |esummary (4 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Enquête sur la couverture vaccinale contre la variole simienne chez les 2SLGBTQI+ et les hommes ayant des rapports sexuels avec des hommes, 2024 : rapport méthodologique. |
|---|
| 500 | |a"Supplier name: Advanis Inc." |
|---|
| 500 | |a"Contract number: 6D142-23-4971." |
|---|
| 500 | |a"Registration number: POR 093-23." |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"The purpose of this survey was to provide an update in 2023/2024 to the information on mpox vaccine coverage for the 2SLGBTQI+ as well as MSM adult populations, and continue to help understand the knowledge, attitudes, and beliefs concerning mpox vaccines (e.g., vaccine effectiveness, vaccine safety, vaccine relevance). This includes exploring reasons for vaccine hesitancy and vaccine refusal and the impact this has on vaccine. Its purpose was also to identify risk factors for transmission of mpox as well as these populations’ willingness to limit high-risk activities amid the current mpox outbreak"--Executive summary, page 4. |
|---|
| 650 | 0|aHuman monkeypox|xVaccination|zCanada|xPublic opinion. |
|---|
| 650 | 0|aPublic opinion|zCanada. |
|---|
| 650 | 0|aSexual minorities|zCanada|xAttitudes. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 710 | 2 |aAdvanis (Firm), |econsultant. |
|---|
| 775 | 08|tEnquête sur la couverture vaccinale contre la variole simienne chez les 2SLGBTQI+ et les hommes ayant des rapports sexuels avec des hommes, 2024 : |w(CaOODSP)9.935236 |
|---|
| 795 | |tMpox immunization coverage survey among 2SLGBTQI+ and men who have sex with men : |w(CaOODSP)9.924899 |
|---|
| 856 | 40|qPDF|s785 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/H14-443-2024-eng.pdf|zMethodological Report |
|---|
| 856 | 40|qPDF|sKB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/H14-443-2024-1-eng.pdf|z(Summary) |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2024/093-23-e/POR093-23-report.html|zMethodological Report |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/public_health_agency_canada/2024/093-23-e/summary/POR093-23-summary.html|zExecutive Summary |
|---|